Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ACE inhibitors and proteinuria

R T Gansevoort1, D de Zeeuw, P E de Jong

  • 1Twenteborg Ziekenhuis, Almelo, The Netherlands.

Pharmacy World & Science : PWS
|December 1, 1996
PubMed
Summary

Angiotensin converting enzyme (ACE) inhibitors effectively reduce proteinuria, a key risk factor for kidney disease progression and cardiovascular mortality. Early reduction in proteinuria with ACE inhibitors predicts better long-term kidney function preservation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Salt-The Forgotten Renal Risk Factor: Sodium Intake Affects Urinary Albumin Excretion Especially in Overweight Subjects. J Intern Med 256: 324-330, 2004.

Journal of the American Society of Nephrology : JASN·2023
Same author

Treating Microalbuminuria-Cosmetic Exercises with Urine Chemistry or Effective Reduction of Clinical Events?: Effects of Fosinopril and Pravastatin on Cardiovascular Events in Subjects with Microalbuminuria. Circulation 110: 2809-2816, 2004.

Journal of the American Society of Nephrology : JASN·2023
Same author

GlycA, a novel pro-inflammatory glycoprotein biomarker is associated with mortality: results from the PREVEND study and meta-analysis.

Journal of internal medicine·2019
Same author

Correction to: Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.

Diabetologia·2019
Same author

Treatable Vascular Risk and Cognitive Performance in Persons Aged 35 Years or Older: Longitudinal Study of Six Years.

The journal of prevention of Alzheimer's disease·2018
Same author

Clinical predictors of escalating care in hepatic and renal cyst infection in autosomal dominant polycystic kidney and liver disease.

The Netherlands journal of medicine·2018

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Proteinuria is a significant risk factor for worsening renal function and cardiovascular mortality.
  • Urinary protein loss can lead to complications like hypoalbuminemia and abnormal lipoprotein profiles.

Purpose of the Study:

  • To review the clinical impact of urinary protein loss.
  • To examine the effects of angiotensin converting enzyme (ACE) inhibitors on proteinuria and related clinical findings.

Main Methods:

  • Review of existing literature on proteinuria, ACE inhibitors, and renal outcomes.
  • Analysis of studies investigating the antiproteinuric effects of ACE inhibitors.
  • Evaluation of the relationship between proteinuria reduction and long-term renal function.

Main Results:

  • ACE inhibitors are more effective at reducing proteinuria than other antihypertensives.
  • The antiproteinuric effect of ACE inhibitors appears independent of the specific renal disease.
  • ACE inhibition improves proteinuria-related issues and prevents renal function decline.
  • Initial response to ACE inhibitors in reducing proteinuria predicts long-term renal function preservation.

Conclusions:

  • ACE inhibitors are valuable in nephrology for managing proteinuria, lowering blood pressure, and preventing renal function loss.
  • Their use is recommended for patients with proteinuric renal diseases, including diabetic and non-diabetic conditions.
  • The mechanism of ACE inhibitors' antiproteinuric effect requires further elucidation.

Related Experiment Videos